Alkermes plc - Ordinary Shares (ALKS) Social Stream
ALKERMES PLC (ALKS) Price Targets From Analysts
Use the tables below to see what analysts covering ALKERMES PLC think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-09 | 7 | $36 | $24 | $29 | $28.56 | 1.54% |
| 2021-11-15 | 7 | $33 | $24 | $28.625 | $28.56 | 0.23% |
| 2021-11-16 | 7 | $33 | $24 | $28.5 | $28.56 | -0.21% |
| 2022-01-23 | 8 | $33 | $22 | $27.777 | $28.56 | -2.74% |
| 2022-01-27 | 8 | $33 | $22 | $28.222 | $28.56 | -1.18% |
| 2022-02-15 | 7 | $33 | $22 | $28.222 | $28.56 | -1.18% |
| 2022-04-13 | 8 | $33 | $22 | $27.666 | $28.56 | -3.13% |
| 2022-04-21 | 8 | $33 | $22 | $27.777 | $28.56 | -2.74% |
| 2022-04-28 | 8 | $36 | $22 | $29.888 | $28.56 | 4.65% |
| 2022-07-19 | 9 | $36 | $22 | $30.4 | $28.56 | 6.44% |
| 2022-08-13 | 10 | $35 | $22 | $30.6 | $28.56 | 7.14% |
| 2022-09-17 | 11 | $35 | $22 | $30.181 | $28.56 | 5.68% |
| 2022-10-13 | 11 | $35 | $22 | $30.181 | $28.56 | 5.68% |
| 2022-10-18 | 10 | $35 | $22 | $30 | $28.56 | 5.04% |
| 2022-11-03 | 11 | $35 | $22 | $30.454 | $28.56 | 6.63% |
| 2022-11-22 | 11 | $36.001 | $26 | $31.5 | $28.56 | 10.29% |
| 2022-12-07 | 10 | $36.001 | $26 | $31.1 | $28.56 | 8.89% |
| 2023-01-06 | 10 | $36.001 | $27 | $31.2 | $28.56 | 9.24% |
| 2023-01-16 | 10 | $36.001 | $27 | $31.3 | $28.56 | 9.59% |
| 2023-01-23 | 10 | $42 | $27 | $32.1 | $28.56 | 12.39% |
| 2023-01-26 | 9 | $42 | $27 | $32.2 | $28.56 | 12.75% |
| 2023-02-08 | 10 | $42 | $27 | $32.2 | $28.56 | 12.75% |
| 2023-02-17 | 10 | $42 | $27 | $32.5 | $28.56 | 13.8% |
| 2023-04-05 | 10 | $45 | $27 | $33 | $28.56 | 15.55% |
| 2023-04-11 | 10 | $45 | $27 | $33.1 | $28.56 | 15.9% |
| 2023-04-20 | 10 | $45 | $27 | $33.2 | $28.56 | 16.25% |
| 2023-04-26 | 9 | $45 | $27 | $33.333 | $28.56 | 16.71% |
| 2023-04-27 | 9 | $48 | $30 | $34.555 | $28.56 | 20.99% |
| 2023-05-21 | 9 | $48 | $30 | $34.666 | $28.56 | 21.38% |
| 2023-06-06 | 9 | $48 | $30 | $34.888 | $28.56 | 22.16% |
| 2023-06-08 | 9 | $48 | $30 | $35.777 | $28.56 | 25.27% |
| 2023-07-26 | 8 | $48 | $30 | $36.125 | $28.56 | 26.49% |
| 2023-08-11 | 8 | $48 | $30 | $36.25 | $28.56 | 26.93% |
| 2023-08-29 | 7 | $48 | $30 | $35.714 | $28.56 | 25.05% |
| 2023-10-12 | 8 | $49 | $30 | $35.714 | $28.56 | 25.05% |
| 2023-10-17 | 9 | $49 | $30 | $35.125 | $28.56 | 22.99% |
| 2023-10-23 | 9 | $49 | $30 | $35.333 | $28.56 | 23.71% |
| 2023-10-28 | 10 | $42 | $27 | $33.333 | $28.56 | 16.71% |
| 2023-11-20 | 12 | $42 | $27 | $33.909 | $28.56 | 18.73% |
The Trend in the Analyst Price Target
Over the past 42 months, ALKS's average price target has gone up $15.18.
ALKS reports an average of 24.75% for its upside potential over the past 45 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-04-26 | 9 | 45 | 27 | 33.333 | 28.38 | 17.45% |
| 2023-06-08 | 9 | 48 | 30 | 36.125 | 31.54 | 14.54% |
| 2023-06-08 | 8 | 48 | 30 | 35.777 | 31.54 | 13.43% |
| 2023-07-11 | 8 | 48 | 30 | 36.125 | 30.24 | 19.46% |
| 2023-08-11 | 7 | 48 | 30 | 35.714 | 28.03 | 27.41% |
ALKS Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 2 | 6 | 0 | 6 | 0 | 0 | 12 |
The Trend in the Broker Recommendations
ALKS's average broker recommendation rating improved by 0.67 over the prior 46 months.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- ALKERMES PLC's average analyst price target is greater than 925.76% of stocks in the large market cap category.
- ALKS has a higher upside potential (average analyst target price relative to current price) than 967.04% of Pharmaceutical Products stocks.
- ALKERMES PLC's number of analysts covering the stock is higher than 1167.37% of stocks in the large market cap category.
- In the context of Pharmaceutical Products stocks, ALKERMES PLC's variance in analysts' estimates is lower than -1404.03% of them.
Stocks similar to ALKERMES PLC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are ALNY, NKTR, and IONS.
View All Top Stocks by Price Target
What is the outlook for ALKS? Use POWR Ratings for clearer insight into price direction.